Sfoglia per Autore
Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept. A case report and literature review
2012-01-01 DE ANGELIS, Federico; DI ROCCO, Alice; Clara, Minotti; Valesini, Guido; Claudio, Cartoni; Riminucci, Mara; Conti, Fabrizio; Erica, Finolezzi; Armiento, Daniele; Grammatico, Sara; Massaro, Laura; Fama, Angelo; Colafigli, Gioia; Catrine, Viccarone; Foa, Roberto; Martelli, Maurizio
Corrigendum to "Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept: A case report and literature review" [Leuk. Res. 36 (2012) e199-e201]
2013-01-01 De Angelis, Federico; Di Rocco, Alice; Minotti, Clara; Valesini, Guido; Cartoni, Claudio; Riminucci, Mara; Conti, Fabrizio; Finolezzi, Erica; Armiento, Daniele; Grammatico, S.; Massaro, L.; Fama, A.; Colafigli, G.; Viccarone, C.; Foã , R.; Martelli, M.
Negative prognostic value of CD34 antigen also if expressed on a small population of acute promyelocitic leukemia cells.
2014-01-01 Breccia, M; De Propris, Ms; Stefanizzi, Caterina; Raponi, Sara; Molica, Matteo; Colafigli, Gioia; Minotti, C; Latagliata, R; Diverio, D; Guarini, Anna; Foa, Roberto
Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy
2015-01-01 Breccia, Massimo; Stefania de Propris, Maria; Molica, Matteo; Colafigli, Gioia; Minotti, Clara; Diverio, Daniela; Latagliata, Roberto; Guarini, Anna; Lo Coco, Francesco; Foa, Roberto
Correlation between Charlson comorbidity index and outcome in patients with chronic phase chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors upfront
2015-01-01 Breccia, M; Molica, Matteo; Colafigli, Gioia; Zacheo, I; Latagliata, Angelo Raffaele; Tafuri, Agostino; Alimena, Giuliana
Management of elderly and unfit patients with chronic lymphocytic leukemia
2016-01-01 Mauro, Francesca Romana; Salaroli, Adriano; Caputo, MARIA DENISE; Colafigli, Gioia; Petrucci, Luigi; Campanelli, Melissa; Ferretti, Antonietta; Guarini, Anna; Foa, Roberto
Clinical characteristics and outcome of patients with autoimmune hemolytic anemia (AIHA) uniformly defined as primary by a diagnostic work-up
2016-01-01 Mauro, Francesca Romana; Coluzzi, S; Paoloni, F; Trastulli, F; Armiento, Daniele; Ferretti, Antonietta; Giovannetti, Gianluca; Colafigli, Gioia; Molica, Matteo; LA ROCCA, Ursula; De Propris, Ms; Caronna, Roberto; Morano, G; Guarini, Anna; Girelli, Gabriella; Foa, Roberto
Long-term impact of molecular response fluctuations in chronic myeloid leukaemia patients treated with imatinib.
2017-01-01 Molica, M; Breccia, M; Colafigli, G; Massaro, F; Quattrocchi, L; Mancini, M; Diverio, D; Latagliata, R; Foà, R.
Body mass index does not impact on molecular response rate of chronic myeloid leukaemia patients treated frontline with second generation tyrosine kinase inhibitors.
2017-01-01 Molica, M; Canichella, M; Colafigli, G; Latagliata, R; Diverio, D; Alimena, G; Foà, R; Breccia, M.
Clinical relevance of silent red blood cell autoantibodies.
2017-01-01 Mauro, Fr; Trastulli, F; Alessandri, C; Valesini, G; Giovannetti, G; Riemma, C; Porrazzo, M; Pepe, S; Colafigli, G; Caputo, Md; De Propris, Ms; Guarini, Ar; Girelli, G; Coluzzi, S; Foà, R
Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients
2017-01-01 Polverelli, Nicola; Breccia, Massimo; Benevolo, Giulia; Martino, Bruno; Tieghi, Alessia; Latagliata, Roberto; Sabattini, Elena; Riminucci, Mara; Godio, Laura; Catani, Lucia; Nicolosi, Maura; Perricone, Margherita; Sollazzo, Daria; Colafigli, Gioia; Campana, Anna; Merli, Francesco; Vitolo, Umberto; Alimena, Giuliana; Martinelli, Giovanni; Lewis, Russell E.; Vianelli, Nicola; Cavo, Michele; Palandri, Francesca
The Eutos long-term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials
2017-01-01 Molica, Matteo; Canichella, Martina; Alunni Fegatelli, Danilo; Colafigli, Gioia; Massaro, Fulvio; Latagliata, Roberto; Foà, Robin; Breccia, Massimo
Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events
2018-01-01 Molica, Matteo; Scalzulli, Emilia; Colafigli, Gioia; Alunni Fegatelli, Danilo; Massaro, Fulvio; Latagliata, Roberto; Foà, Robin; Breccia, Massimo
Ten-year outcome of chronic-phase chronic myeloid leukemia patients treated with imatinib in real life
2019-01-01 Molica, Matteo; Colafigli, Gioia; Scalzulli, Emilia; Alunni Fegatelli, Danilo; Chiatamone Ranieri, Sofia; Rizzo, Lorenzo; Diverio, Daniela; Efficace, Fabio; Latagliata, Roberto; Foà, Robin; Breccia, Massimo
Identification of predictive factors for overall survival at baseline and during azacitidine treatment in high-risk myelodysplastic syndrome patients treated in the clinical practice
2019-01-01 Scalzulli, Emilia; Molica, Matteo; Alunni Fegatelli, Danilo; Colafigli, Gioia; Rizzo, Lorenzo; Mancini, Marco; Efficace, Fabio; Latagliata, Roberto; Foà, Robin; Breccia, Massimo
Digital droplet PCR as a predictive tool for successful discontinuation outcome in chronic myeloid leukemia. is it time to introduce it in the clinical practice?
2020-01-01 Colafigli, G.; Scalzulli, E.; Di Prima, A.; Pepe, S.; Loglisci, M. G.; Diverio, D.; Martelli, M.; Foa, R.; Breccia, M.
Therapeutic strategies in low and high-risk MDS: What does the future have to offer?
2021-01-01 Scalzulli, E.; Pepe, S.; Colafigli, G.; Breccia, M.
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients
2021-01-01 Scalzulli, Emilia; Caocci, Giovanni; Efficace, Fabio; Rizzo, Lorenzo; Colafigli, Gioia; Di Prima, Alessio; Pepe, Sara; Alunni Fegatelli, Danilo; Carmosino, Ida; Diverio, Daniela; Latagliata, Roberto; La Nasa, Giorgio; Martelli, Maurizio; Foà, Robin; Breccia, Massimo
Long-term follow-up of late chronic phase chronic myeloid leukemia patients treated with imatinib after interferon failure: a single center experience
2021-01-01 Pepe, S.; Scalzulli, E.; Colafigli, G.; Di Prima, A.; Mancini, M.; Diverio, D.; Latagliata, R.; Martelli, M.; Foa, R.; Breccia, M.
Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients
2022-01-01 Breccia, M.; Scalzulli, E.; Pepe, S.; Colafigli, G.; Bisegna, M. L.; Capriata, M.; Martelli, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept. A case report and literature review | 1-gen-2012 | DE ANGELIS, Federico; DI ROCCO, Alice; Clara, Minotti; Valesini, Guido; Claudio, Cartoni; Riminucci, Mara; Conti, Fabrizio; Erica, Finolezzi; Armiento, Daniele; Grammatico, Sara; Massaro, Laura; Fama, Angelo; Colafigli, Gioia; Catrine, Viccarone; Foa, Roberto; Martelli, Maurizio | |
| Corrigendum to "Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept: A case report and literature review" [Leuk. Res. 36 (2012) e199-e201] | 1-gen-2013 | De Angelis, Federico; Di Rocco, Alice; Minotti, Clara; Valesini, Guido; Cartoni, Claudio; Riminucci, Mara; Conti, Fabrizio; Finolezzi, Erica; Armiento, Daniele; Grammatico, S.; Massaro, L.; Fama, A.; Colafigli, G.; Viccarone, C.; Foã , R.; Martelli, M. | |
| Negative prognostic value of CD34 antigen also if expressed on a small population of acute promyelocitic leukemia cells. | 1-gen-2014 | Breccia, M; De Propris, Ms; Stefanizzi, Caterina; Raponi, Sara; Molica, Matteo; Colafigli, Gioia; Minotti, C; Latagliata, R; Diverio, D; Guarini, Anna; Foa, Roberto | |
| Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy | 1-gen-2015 | Breccia, Massimo; Stefania de Propris, Maria; Molica, Matteo; Colafigli, Gioia; Minotti, Clara; Diverio, Daniela; Latagliata, Roberto; Guarini, Anna; Lo Coco, Francesco; Foa, Roberto | |
| Correlation between Charlson comorbidity index and outcome in patients with chronic phase chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors upfront | 1-gen-2015 | Breccia, M; Molica, Matteo; Colafigli, Gioia; Zacheo, I; Latagliata, Angelo Raffaele; Tafuri, Agostino; Alimena, Giuliana | |
| Management of elderly and unfit patients with chronic lymphocytic leukemia | 1-gen-2016 | Mauro, Francesca Romana; Salaroli, Adriano; Caputo, MARIA DENISE; Colafigli, Gioia; Petrucci, Luigi; Campanelli, Melissa; Ferretti, Antonietta; Guarini, Anna; Foa, Roberto | |
| Clinical characteristics and outcome of patients with autoimmune hemolytic anemia (AIHA) uniformly defined as primary by a diagnostic work-up | 1-gen-2016 | Mauro, Francesca Romana; Coluzzi, S; Paoloni, F; Trastulli, F; Armiento, Daniele; Ferretti, Antonietta; Giovannetti, Gianluca; Colafigli, Gioia; Molica, Matteo; LA ROCCA, Ursula; De Propris, Ms; Caronna, Roberto; Morano, G; Guarini, Anna; Girelli, Gabriella; Foa, Roberto | |
| Long-term impact of molecular response fluctuations in chronic myeloid leukaemia patients treated with imatinib. | 1-gen-2017 | Molica, M; Breccia, M; Colafigli, G; Massaro, F; Quattrocchi, L; Mancini, M; Diverio, D; Latagliata, R; Foà, R. | |
| Body mass index does not impact on molecular response rate of chronic myeloid leukaemia patients treated frontline with second generation tyrosine kinase inhibitors. | 1-gen-2017 | Molica, M; Canichella, M; Colafigli, G; Latagliata, R; Diverio, D; Alimena, G; Foà, R; Breccia, M. | |
| Clinical relevance of silent red blood cell autoantibodies. | 1-gen-2017 | Mauro, Fr; Trastulli, F; Alessandri, C; Valesini, G; Giovannetti, G; Riemma, C; Porrazzo, M; Pepe, S; Colafigli, G; Caputo, Md; De Propris, Ms; Guarini, Ar; Girelli, G; Coluzzi, S; Foà, R | |
| Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients | 1-gen-2017 | Polverelli, Nicola; Breccia, Massimo; Benevolo, Giulia; Martino, Bruno; Tieghi, Alessia; Latagliata, Roberto; Sabattini, Elena; Riminucci, Mara; Godio, Laura; Catani, Lucia; Nicolosi, Maura; Perricone, Margherita; Sollazzo, Daria; Colafigli, Gioia; Campana, Anna; Merli, Francesco; Vitolo, Umberto; Alimena, Giuliana; Martinelli, Giovanni; Lewis, Russell E.; Vianelli, Nicola; Cavo, Michele; Palandri, Francesca | |
| The Eutos long-term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials | 1-gen-2017 | Molica, Matteo; Canichella, Martina; Alunni Fegatelli, Danilo; Colafigli, Gioia; Massaro, Fulvio; Latagliata, Roberto; Foà, Robin; Breccia, Massimo | |
| Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events | 1-gen-2018 | Molica, Matteo; Scalzulli, Emilia; Colafigli, Gioia; Alunni Fegatelli, Danilo; Massaro, Fulvio; Latagliata, Roberto; Foà, Robin; Breccia, Massimo | |
| Ten-year outcome of chronic-phase chronic myeloid leukemia patients treated with imatinib in real life | 1-gen-2019 | Molica, Matteo; Colafigli, Gioia; Scalzulli, Emilia; Alunni Fegatelli, Danilo; Chiatamone Ranieri, Sofia; Rizzo, Lorenzo; Diverio, Daniela; Efficace, Fabio; Latagliata, Roberto; Foà, Robin; Breccia, Massimo | |
| Identification of predictive factors for overall survival at baseline and during azacitidine treatment in high-risk myelodysplastic syndrome patients treated in the clinical practice | 1-gen-2019 | Scalzulli, Emilia; Molica, Matteo; Alunni Fegatelli, Danilo; Colafigli, Gioia; Rizzo, Lorenzo; Mancini, Marco; Efficace, Fabio; Latagliata, Roberto; Foà, Robin; Breccia, Massimo | |
| Digital droplet PCR as a predictive tool for successful discontinuation outcome in chronic myeloid leukemia. is it time to introduce it in the clinical practice? | 1-gen-2020 | Colafigli, G.; Scalzulli, E.; Di Prima, A.; Pepe, S.; Loglisci, M. G.; Diverio, D.; Martelli, M.; Foa, R.; Breccia, M. | |
| Therapeutic strategies in low and high-risk MDS: What does the future have to offer? | 1-gen-2021 | Scalzulli, E.; Pepe, S.; Colafigli, G.; Breccia, M. | |
| Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients | 1-gen-2021 | Scalzulli, Emilia; Caocci, Giovanni; Efficace, Fabio; Rizzo, Lorenzo; Colafigli, Gioia; Di Prima, Alessio; Pepe, Sara; Alunni Fegatelli, Danilo; Carmosino, Ida; Diverio, Daniela; Latagliata, Roberto; La Nasa, Giorgio; Martelli, Maurizio; Foà, Robin; Breccia, Massimo | |
| Long-term follow-up of late chronic phase chronic myeloid leukemia patients treated with imatinib after interferon failure: a single center experience | 1-gen-2021 | Pepe, S.; Scalzulli, E.; Colafigli, G.; Di Prima, A.; Mancini, M.; Diverio, D.; Latagliata, R.; Martelli, M.; Foa, R.; Breccia, M. | |
| Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients | 1-gen-2022 | Breccia, M.; Scalzulli, E.; Pepe, S.; Colafigli, G.; Bisegna, M. L.; Capriata, M.; Martelli, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile